PSMA PET-CT in patients with high-risk prostate cancer
Professor Michael Hofman introduces the findings from the new study:
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.
Michael S Hofman, Nathan Lawrentschuk, Roslyn J Francis, Colin Tang, Ian Vela, Paul Thomas, Natalie Rutherford, Jarad M Martin, Mark Frydenberg, Ramdave Shakher, Lih-Ming Wong, Kim Taubman, Sze Ting Lee, Edward Hsiao, Paul Roach, Michelle Nottage, Ian Kirkwood, Dickon Hayne, Emma Link, Petra Marusic, Anetta Matera, Alan Herschtal, Amir Iravani, Rodney J Hicks, Scott Williams, Declan G Murphy, for the proPSMA Study Group Collaborators*
Read the study: https://www.thelancet.com/jour....nals/lancet/article/
NOTE: At 0:57, the second box in the sequence should read 'Randomised (n=302)'
Visit The Lancet at https://www.thelancet.com/jour....nals/lancet/home?dgc
Find out more at https://www.thelancet.com/?dgc....id=youtube_video_lan
* * *
Continue this conversation on social! Follow us today at…
https://Twitter.com/TheLancet
https://facebook.com/TheLancetMedicalJournal
https://LinkedIn.com/company/the-lancet
-
Category
No comments found